Header Ads

Japan's Kyodo unveils MyoFree tablet with new eye strain-reducing technology

TECNO
Infinix
MyoFree eye-care tablet aims to reduce visual stress through unique viewing technology.
Japan's Kyodo unveils MyoFree tablet with new eye strain-reducing technology
New tab with eye strain-reducing

New type of eye-care tablet

Kyodo, a Japanese manufacturer, introduced MyoFree, a new eye-care tablet that is designed to help reduce visual stress during extended screen use through a unique technology called "parallel vision."


The company describes it as the world's first device that allows users to rest their eyes while looking at a screen.

Unlike conventional tablets, MyoFree uses a special viewing system that works with dedicated circularly polarized glasses. This creates a parallel vision effect, where each eye looks at a separate image, similar to viewing an object from a distance.

The system works with a dedicated tablet and circular polarizing glasses, which are designed to be used together. Kyodo says the technology aims to provide a different viewing experience while helping users reduce visual stress.

The company also noted that MyoFree is recommended by ophthalmologists. However, the tablet and its dedicated glasses are not classified as medical devices under Japan's Pharmaceuticals and Medical Devices Act.

Beyond its consumer-focused application, Kyodo is also using MyoFree in its Eye Care Project, an initiative aimed at promoting eye care and visual wellness among different groups.

The program covers athletes from sports such as soccer, futsal, boxing, basketball, ice hockey, and motorsports. It also extends to elementary, middle, high school, and university students, children with developmental disabilities, and elderly individuals.

Kyodo plans to expand the initiative through cooperation with the Eye Care Wellness Japan Association.

Availability

The company has yet to announce the tablet's regular retail price and international availability.

It is worth noting that the MyoFree tablet and its dedicated glasses are not classified as medical devices. The company also clarifies that its eye-care concept does not guarantee specific medical effects or benefits.

What do you think?

Source: Kyodo

No comments

Powered by Blogger.
close
gizguide